- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection
Patent holdings for IPC class A61P 37/06
Total number of patents in this class: 7263
10-year publication summary
|
135
|
244
|
430
|
347
|
515
|
592
|
625
|
653
|
603
|
71
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10481 |
109 |
| The Regents of the University of California | 20366 |
75 |
| Chugai Seiyaku Kabushiki Kaisha | 1384 |
52 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3354 |
52 |
| F. Hoffmann-La Roche AG | 7881 |
44 |
| Regeneron Pharmaceuticals, Inc. | 4510 |
41 |
| Bristol-myers Squibb Company | 4809 |
40 |
| Janssen Biotech, Inc. | 1626 |
40 |
| Takeda Pharmaceutical Company Limited | 2712 |
37 |
| Eli Lilly and Company | 3965 |
37 |
| Selecta Biosciences, Inc. | 183 |
37 |
| The Board of Trustees of the Leland Stanford Junior University | 6590 |
36 |
| Genentech, Inc. | 4038 |
35 |
| Ono Pharmaceutical Co., Ltd. | 426 |
35 |
| The General Hospital Corporation | 4794 |
33 |
| Daiichi Sankyo Company, Limited | 1876 |
32 |
| Astellas Pharma Inc. | 1049 |
31 |
| Incyte Corporation | 1039 |
31 |
| Osaka University | 3362 |
31 |
| The Trustees of the University of Pennsylvania | 4382 |
28 |
| Other owners | 6407 |